Ablate and Pace HIS Study

Recruiting N/A Interventional Study
HIS Bundle Pacing Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
University Hospitals, Leicester · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and estimates suggest its prevalence is increasing. Despite the advances in AF ablation strategies, the outcome of ablation procedures in persistent AF is still unsatisfactory. In addition, many patients are not candidates for ablation due to advanced age, comorbidities and previous failed ablation procedures. It is well kn…
Trial Locations

Sorted by distance from Kentucky

Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged 18 or above * Symptomatic AF, New York Heart Association (NYHA) class II-IV * Willing to consent for the study * AF regardless type, deemed not suitable for rhythm control strategy that has been referred for AVN ablation with one of the following: 1. Impaired LV functi…
Contacts

Mokhtar Ibrahim, Dr

0116 2583887

mokhtar.ibrahim@uhl-tr.nhs.uk

CONTACT